Altimmune ALT
NASDAQ ALT
$2.76 -0.10 (-3.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Altimmune (ALT) Non Operating Interest Expenses (2010 - 2026)

Updated

Altimmune (ALT) posted Non Operating Interest Expenses of $1.1 million for Q2 2026, up 315.5% from $264,000 a year earlier and up 2.7% from the prior quarter.

Analysis

Altimmune (ALT) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Altimmune was $3.54 million; for FY2025, it came in at $1.64 million.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 180.5% (FY2020 to FY2025).
  • In prior years, Altimmune's Non Operating Interest Expenses was $9,000 in FY2024 (-74.3%), $35,000 in FY2023 (+337.5%), $8,000 in FY2022 (+60.0%) and $5,000 in FY2021 (-46.9%).
  • The Q2 2026 figure stands as the highest quarterly Non Operating Interest Expenses since Q4 2010.
  • On a year-over-year basis, Non Operating Interest Expenses increased in 1 of the last four quarters, with growth averaging 46.6%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2022, with growth of 416.7%; the weakest was Q2 2023, with a decline of 96.9%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.07 million (Q1 2026), $876,000 (Q4 2025) and $495,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Altimmune 556.20 Mn 556.20 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 1.07 Mn
Dec 31, 2025 876,000.00
Sep 30, 2025 495,000.00
Jun 30, 2025 264,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 6,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 1,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 2,000.00
Dec 31, 2022 -183,000.00
Sep 30, 2022 64,000.00
Jun 30, 2022 65,000.00
Mar 31, 2022 62,000.00
Dec 31, 2021 -62,000.00
Sep 30, 2021 33,000.00
API Access

Altimmune Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEY